全文获取类型
收费全文 | 1177篇 |
免费 | 25篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 31篇 |
妇产科学 | 4篇 |
基础医学 | 220篇 |
口腔科学 | 28篇 |
临床医学 | 91篇 |
内科学 | 171篇 |
皮肤病学 | 33篇 |
神经病学 | 25篇 |
特种医学 | 87篇 |
外科学 | 232篇 |
预防医学 | 57篇 |
眼科学 | 96篇 |
药学 | 77篇 |
中国医学 | 5篇 |
肿瘤学 | 41篇 |
出版年
2021年 | 10篇 |
2016年 | 13篇 |
2014年 | 13篇 |
2013年 | 22篇 |
2012年 | 21篇 |
2011年 | 41篇 |
2010年 | 31篇 |
2009年 | 23篇 |
2008年 | 28篇 |
2007年 | 36篇 |
2006年 | 31篇 |
2005年 | 27篇 |
2004年 | 30篇 |
2003年 | 31篇 |
2002年 | 26篇 |
2001年 | 21篇 |
2000年 | 17篇 |
1999年 | 18篇 |
1998年 | 14篇 |
1997年 | 17篇 |
1996年 | 8篇 |
1995年 | 9篇 |
1994年 | 11篇 |
1992年 | 34篇 |
1991年 | 40篇 |
1990年 | 37篇 |
1989年 | 44篇 |
1988年 | 40篇 |
1987年 | 42篇 |
1986年 | 36篇 |
1985年 | 54篇 |
1984年 | 28篇 |
1983年 | 19篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1980年 | 17篇 |
1979年 | 30篇 |
1978年 | 19篇 |
1977年 | 17篇 |
1976年 | 20篇 |
1975年 | 31篇 |
1974年 | 12篇 |
1973年 | 19篇 |
1972年 | 17篇 |
1970年 | 15篇 |
1969年 | 21篇 |
1968年 | 8篇 |
1967年 | 21篇 |
1966年 | 12篇 |
1965年 | 8篇 |
排序方式: 共有1203条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
7.
É. M. Kaz'mina I. I. Fedorov Ya. É. Bezchinskii N. V. Kiseleva N. A. Novikov G. G. Galegov A. P. Arzamastsev 《Pharmaceutical Chemistry Journal》1989,23(10):830-836
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 23, No. 10, pp. 1217–1223, October, 1989. 相似文献
8.
9.
Sluggish wounds are characterized by impaired proportions of proinflammatory cytokines, deficiency of fibrogenic growth factors, imbalance in the system of matrix metalloproteinases and their inhibitors this preventing reparation. The study was made of biopsies obtained from patients with sluggish wounds before the treatment, 5, 10 and 15 days after transplantation on the wound of allogenic EGF-stimulated cryopreserved epidermis. The wound closure with biologically active coat was followed by the reduction of expression of proinflammatory cytokines and return to their normal correlations, higher production of fibrogenic growth factors, restoration of balance in the expression of MMP-9 and TIMP-1/TIMP-2. 相似文献
10.
This paper describes the tragic case of a young woman who died of cancer of
the colon after successfully donating eggs to her younger sister. Although
there is no direct link between her operation and the subsequent
development of bowel carcinoma, this case imparts a feeling of unease when
seen in conjunction with other cases reported during the last few years. It
is a reminder that little is known of the long-term consequences of some
aspects of assisted conception. Women undergoing ovarian stimulation for
themselves or a matched recipient have the right to be advised, in an
agreed format, that there is some concern about unproven potential risks
from the stimulatory drugs. The safety of egg donors must assume priority
over all other considerations, including lack of donors or any moral
position. The recent decision by the Human Fertilisation and Embryology
Authority (HFEA) to withdraw any form of payment or recompense to egg
donors does not seem to us to be based on a balance of scientific advances,
patient needs and the ethics of gamete supply. They state that the
intention to withdraw payments was implicit in the 1990 Human Fertilisation
and Embryology (HFE) Act. However the Act was based on the Warnock report
made 6 years earlier. Even in 1990 ovum donation was uncommon and fertility
drugs had not yet caused any unease. The Act provided the HFEA with
discretionary powers to issue directions so that the future policies would
be consistent with any emerging new medical evidence. It is imperative that
the HFEA provide convincing evidence on how the current policy of payment
to donors harms society, donors or recipients, and how in the UK the new
policy will improve medical practice in assisted conception. Successful
pilot studies must precede the implementation of any new policy. Failure to
do this could cause irreversible harm to the practice of assisted
conception using donor gametes, which will ultimately be against the basic
aims of the 1990 HFE Act.
相似文献